"Enzyme cost is not the issue, it is development speed
Wed 4 Feb 2015, 11:15:
Enzymes for a Brighter Living
Oliver May received his PhD from University of Stuttgart where he studied structure function and evolutionary relationship of cyclic amidases. Between 1998 and 2000 he was postdoc at California Institute of Technology (US) where he designed enzymes for amino acid production processes. He joined Degussa (now Evonik Industries) in 2000 developing and implementing various biotransformation processes for fine chemicals, personal care and flavor applications.
Between 2004 and 2006 he headed Degussa’s Service Center Biocatalysis and thereafter joined DSM as Competence Manager and later Corporate Scientist for Biocatalysis. In 2011 he joined the DSM Innovation Center and was responsible as R&D Director for the EBA Bio-based Products & Services for a broad biofuels and platform chemicals R&D portfolio which is now commercialized in Joint Ventures such as POET-DSM Advanced Biofuels and Reverdia as well as other customers. At the beginning of this year he moved to the DSM Biotech Center in Delft.